119 related articles for article (PubMed ID: 2679560)
21. Specific interaction between cartilage proteoglycans and hyaluronic acid at the chondrocyte cell surface.
Sommarin Y; Heinegård D
Biochem J; 1983 Sep; 214(3):777-84. PubMed ID: 6626157
[TBL] [Abstract][Full Text] [Related]
22. Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants.
Todhunter RJ; Fubini SL; Wootton JA; Lust G
J Rheumatol; 1996 Jul; 23(7):1207-13. PubMed ID: 8823694
[TBL] [Abstract][Full Text] [Related]
23. The affinity of newly synthesized proteoglycan for hyaluronic acid can be enhanced by exposure to mild alkali.
Plaas AH; Sandy JD
Biochem J; 1986 Feb; 234(1):221-3. PubMed ID: 3707543
[TBL] [Abstract][Full Text] [Related]
24. Passive loss of proteoglycan from articular cartilage explants.
Bolis S; Handley CJ; Comper WD
Biochim Biophys Acta; 1989 Dec; 993(2-3):157-67. PubMed ID: 2512986
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase inhibitor CGS 27023A protects COMP and proteoglycan in the bovine articular cartilage but not the release of their fragments from cartilage after prolonged stimulation in vitro with IL-1 alpha.
Ganu V; Melton R; Wang W; Roberts D
Ann N Y Acad Sci; 1999 Jun; 878():607-11. PubMed ID: 10415786
[No Abstract] [Full Text] [Related]
26. Degradation of proteoglycan in articular cartilage.
Sandy JD; Brown HL; Lowther DA
Biochim Biophys Acta; 1978 Nov; 543(4):536-44. PubMed ID: 31190
[TBL] [Abstract][Full Text] [Related]
27. Aggregation of cartilage proteoglycans. II Evidence for the presence of a hyaluronate-binding region on proteoglycans from osteoarthritic cartilage.
Brandt KD; Palmoski MJ; Perricone E
Arthritis Rheum; 1976; 19(6):1308-14. PubMed ID: 999739
[TBL] [Abstract][Full Text] [Related]
28. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro.
Tyler JA
Biochem J; 1985 Jan; 225(2):493-507. PubMed ID: 3919707
[TBL] [Abstract][Full Text] [Related]
29. Four classes of cell-associated proteoglycans in suspension cultures of articular-cartilage chondrocytes.
Sommarin Y; Heinegård D
Biochem J; 1986 Feb; 233(3):809-18. PubMed ID: 3707528
[TBL] [Abstract][Full Text] [Related]
30. Topographic variation in biglycan and decorin synthesis by articular cartilage in the early stages of osteoarthritis: an experimental study in sheep.
Little CB; Ghosh P; Bellenger CR
J Orthop Res; 1996 May; 14(3):433-44. PubMed ID: 8676257
[TBL] [Abstract][Full Text] [Related]
31. In vivo effects of interleukin-1 on articular cartilage. Prolongation of proteoglycan metabolic disturbances in old mice.
van Beuningen HM; Arntz OJ; van den Berg WB
Arthritis Rheum; 1991 May; 34(5):606-15. PubMed ID: 2025312
[TBL] [Abstract][Full Text] [Related]
32. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
[TBL] [Abstract][Full Text] [Related]
33. Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1.
Fukuda K; Dan H; Takayama M; Kumano F; Saitoh M; Tanaka S
J Pharmacol Exp Ther; 1996 Jun; 277(3):1672-5. PubMed ID: 8667237
[TBL] [Abstract][Full Text] [Related]
34. Identification of a hyaluronic acid-binding protein that interferes with the preparation of high-buoyant-density proteoglycan aggregates from adult human articular cartilage.
Roughley PJ; White RJ; Poole AR
Biochem J; 1985 Oct; 231(1):129-38. PubMed ID: 4062883
[TBL] [Abstract][Full Text] [Related]
35. Proteoglycan metabolism in isolated chondrocytes from human cartilage and in short-term tissue-cultured human articular cartilage.
Verbruggen G; Veys EM; Malfait AM; Schatteman L; Wieme N; Heynen G; Vanhoutte V; Broddelez C
Clin Exp Rheumatol; 1989; 7(1):13-7. PubMed ID: 2706816
[TBL] [Abstract][Full Text] [Related]
36. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose.
Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M
J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643
[TBL] [Abstract][Full Text] [Related]
37. Complexity of proteoglycan organization in articular cartilage: recent observations.
Poole AR
J Rheumatol Suppl; 1983 Dec; 11():70-5. PubMed ID: 6583420
[TBL] [Abstract][Full Text] [Related]
38. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo.
van Beuningen HM; van der Kraan PM; Arntz OJ; van den Berg WB
Ann Rheum Dis; 1993 Mar; 52(3):185-91. PubMed ID: 8484670
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants.
Sah RL; Chen AC; Grodzinsky AJ; Trippel SB
Arch Biochem Biophys; 1994 Jan; 308(1):137-47. PubMed ID: 8311446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
